The FEI has announced the final decisions in three anti-doping cases:

Al Thani Receives 27-Month Suspension
The FEI Tribunal has issued its Final Decision in the case involving Nasser Khalifa N.J Al Thani (QAT) and the horse Brookleigh Caspar (FEI ID AUS40748) at the 120km one-star Endurance competition at Mesaieed in Doha (QAT) on April 11, 2014, following a positive finding for Prohibited Substances.
Samples taken from the horse on April 11, 2014 returned positive for the Banned Substance Heptaminol and Controlled Medications Phenylbutazone, Meloxicam and Dexamethasone. Heptaminol is a stimulant that dilates blood vessels. Phenylbutazone and Meloxicam are non-steroidal anti-inflammatory drugs (NSAIDs) used for pain relief, and Dexamethasone is a corticosteroid with anti-inflammatory effect.

Controlled Medications are substances that are regularly used to treat horses, but which are not allowed in competition in order to maintain a level playing field. Banned Substances should never be found in the horse.

Advertisement